AVXL
Anavex Life Sciences Corporation
-22.55%
$11.75 - $9.10
Feb 7th 2023 - Mar 21st 2023
Jan, 16, 2023
His intelligent and concise analysis is the by far... See more
Jan, 12, 2023
Best analysis of all things avxl on the web!
SAVA
Cassava Sciences Inc
-13.96%
$29.88 - $25.71
Feb 7th 2023 - Mar 21st 2023
Divihomes is Now Live
Check out our new advanced search tool that can help you find the best home services in your area.
Search & Match
Instant Communication
Unbiased Reviews
100% Free
TGTX
TG Therapeutics Inc
-19.05%
$18.43 - $14.92
Feb 7th 2023 - Mar 21st 2023
Mar, 21, 2023
$TGTX Options Flow 🤖 analysis suggests a bullish ... See more
Mar, 8, 2023
In pooled post hoc analyses of ULTIMATE I and II, ... See more
Jan, 16, 2023
His intelligent and concise analysis is the by far the best free DD (and probably better than any paid for) on the web.
Jan, 12, 2023
Best analysis of all things avxl on the web!
Jan, 12, 2023
$AVXL they have an Alzheimer’s disease modifying treatment and are looking to bring the full data, once complete analysis is finished, to regulatory agencies to commercialize around the globe, asap.🔥❤️ IMO we are in good, albeit slow, hands😂
Dec, 21, 2022
$AVXL This was a very excellent and magnificent analysis.
Dec, 9, 2022
This analysis was also significant and showed a clear benefit of drug. 1/2
Dec, 7, 2022
Sub group analysis for 50 mg dosing is remarkable.
Dec, 1, 2022
$AVXL Very good analysis of the so called Biogen breakthrough.
Nov, 27, 2022
ANAVEX2-73 study designed with a perfect design and power analysis, with the medicine of the future.
Oct, 20, 2022
We trust your analysis.
Nov, 7, 2022
$SAVA Lost in all the analysis are some simple facts; The drug is safe.
Mar, 21, 2023
$TGTX Options Flow 🤖 analysis suggests a bullish outlook for the stock.
Mar, 8, 2023
In pooled post hoc analyses of ULTIMATE I and II, ublituximab was associated with significant treatment benefit across multiple efficacy measures at Week 96 versus teriflunomide in participants who had not received prior DMT.